Advanced Strategies for Eliminating the cccDNA of HBV

Jingwu Dong1, Jie Ying2, Xiaoyan Qiu2

  • 1Department of Gastroenterology, Xuyi People's Hospital, 28 Hongwu Road, Xuyi, 211700, Jiangsu, People's Republic of China.

Insights

Eliminating covalently closed circular DNA (cccDNA) from hepatocytes is key to curing persistent hepatitis B virus (HBV) infection. This review explores current and future strategies for HBV cccDNA clearance.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Persistent hepatitis B virus (HBV) infection is linked to hepatocyte cccDNA episomes.
  • cccDNA levels correlate with HBeAg status, being higher in HBeAg-positive patients.
  • Trace cccDNA can persist even after HBV infection resolution.

Purpose of the Study:

  • To review recent strategies aimed at eliminating HBV cccDNA.
  • To discuss future therapeutic developments for chronic hepatitis B.

Main Methods:

  • Literature review of studies on HBV cccDNA elimination strategies.
  • Analysis of current and emerging treatment approaches for chronic hepatitis B.

Main Results:

  • cccDNA presence is a hallmark of persistent HBV infection.
  • cccDNA clearance represents a potential curative approach for HBV.
  • Various strategies are being investigated for cccDNA elimination.

Conclusions:

  • Effective clearance of HBV cccDNA is crucial for a definitive cure.
  • Ongoing research focuses on developing novel treatments to eradicate cccDNA.
  • Future therapies aim to achieve complete viral clearance in chronic hepatitis B patients.